Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001373604-25-000097·BML Investment Partners, L.P.
Schedule 13D ownership disclosure
ELEVATION ONCOLOGY INC
Common stock, par value $0.0001 per share · CUSIP: 28623U101
Event date: 2025-07-23
- Filing-level shares
- 0
- Percent of class
- 0%
- BML Investment Partners, L.P.Reported CIK 0001373604
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-25-000097
- Form type
- SCHEDULE 13D/A
- Filer
- BML Investment Partners, L.P.
- CIK
- CIK 1373604
- Filed
- Jul 28, 2025
- Reporting period
- Jul 23, 2025
- Description
- Schedule 13D beneficial ownership